The t(9;22) chromosome translocation originating the BCR-ABL1 fusion oncoprotein is detected in more than 95% of patients with CML representing the hallmark of the disease [1]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.